Corporate Employer Benefit Programmes

For large corporates—particularly those operating employee benefit captives—KINsight functions as working-age risk-reduction infrastructure. Early identification of inherited genetic cancer risk materially reduces catastrophic late-stage cancer diagnosis during peak employment years, lowering high-severity claims, reducing team disruption and loss of key staff, stabilising captive loss experience, and improving long-term funding predictability.

By addressing correlated family risk upstream, KINsight reduces claims volatility, protects captive capital, and limits disruption from prolonged absence, disability, and premature workforce exit—strengthening the employer’s long-term risk position.

KINsight enables EB Programs to act on cancers whose costs their actuaries will already have priced in and they already expect to pay – saving lives and delivering material cost savings without adding unbudgeted spend.